共 70 条
- [11] Yudkin P., Ellison G.W., Ghezzi A., Et al., Overview of azathioprine treatment in multiple sclerosis, Lancet, 338, pp. 1051-1055, (1991)
- [12] Fazekas J.M., Deisenhammer F., Strasser-Fuchs S., Et al., Randomized placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis, Lancet, 349, pp. 589-593, (1997)
- [13] Achiron A., Gabbay U., Gilad R., Et al., Intravenous immunoglobulin treatment in multiple sclerosis - Effect on relapses, Neurology, 50, pp. 398-402, (1998)
- [14] Sorensen P.S., Wanscher B., Jensen C.V., Et al., Intravenous immunoglobulin G reduces MRI activity in relapsing remitting multiple sclerosis, Neurology, 50, pp. 1273-1281, (1998)
- [15] Rieckmann P., Toyka K.V., Escalating immunotherapy of multiple sclerosis, Eur Neurol, 42, pp. 121-127, (1999)
- [16] Cursiefen S., Fachenecker P., Rieckmann P., Et al., Mitoxantrone (Novantron®) in therapy of severe multiple sclerosis. A retrospective study of 15 patients, Nervenarzt, 70, pp. 723-731, (1999)
- [17] Hartung H.P., Gonsette R., Mitoxantrone in progressive multiple sclerosis (MS): A placebo-controlled, randomized, observer-blind European phase III multicenter study - Clinical results, Mult Scler, 4, (1998)
- [18] Pette M., Hartung H.P., Toyka K.V., Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies, Nervenarzt, 65, pp. 271-274, (1994)
- [19] Weiner H.L., Mackin G.A., Orav E.J., Et al., Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: Final report of the Northeast Cooperative Multiple Sclerosis Treatment Group, Neurology, 43, pp. 910-918, (1993)
- [20] Weilbach F.X., Gold R., Disease modifying treatments for multiple sclerosis: What is on the horizon?, CNS Drugs, 11, 2, pp. 133-157, (1999)